Korean Obesity drugs stocks

GLP-1 obesity treatments — development stages, licensing deals and contract manufacturing at Korean pharma and biotech companies.

Articles, 7 days70
Articles, 2 weeks96
Companies, 2 weeks17
Most mentionedHanmi Pharm55 articles

Most-mentioned Obesity drugs companies 2 weeks

#CompanyMarketArticlesShareLast mention
1Hanmi Pharm 128940KOSPI5557.3%11:50
2Daewon Pharmaceutical 003220KOSPI1919.8%Oct 27 10:41
3Samsung Electronics 005930KOSPI55.2%12:19
4D&D Pharmatech 347850KOSDAQ44.2%Oct 29 08:30
5글로벌테크놀로지 486510KOSDAQ44.2%09:46
6Inventage Lab 389470KOSDAQ22.1%Oct 29 09:00
7Samsung Biologics 207940KOSPI22.1%Oct 20 11:41
8GC Genome 340450KOSDAQ22.1%11:50
9Dong-a ST 170900KOSPI11.0%09:46
10HK inno.N 195940KOSDAQ11.0%Oct 19 17:44
11Cosmax 192820KOSPI11.0%Oct 28 17:04
12Onconic Therapeutics 476060KOSDAQ11.0%Oct 22 11:29
13Otoki 007310KOSPI11.0%Oct 26 16:42
14IL Dong Pharmaceutical 249420KOSPI11.0%Oct 29 13:15

Roundup articles listing five or more companies are excluded. A mention is not a recommendation.

Top stories 2 weeks, by number of outlets

  1. 1
  2. 2
    한미약품, 삼중작용 차세대 비만약 '잔트루타이드'로 명명
    4 outlets · 4 articlesFirst report Oct 23 17:18 아시아경제Hanmi Pharm
  3. 3
    마운자로 일라이릴리, 삼전 제치고 세계 시총 12위
    4 outlets · 4 articlesFirst report Oct 30 10:04 연합뉴스경제Samsung Electronics
  4. 4
    대원제약 "당뇨·비만약 임상 2건 美학회서 발표"
    3 outlets · 3 articlesFirst report Oct 23 09:56 뉴시스경제Daewon Pharmaceutical
  5. 5
  6. 6

Latest articles Korean headlines